Here are relevant reports on : personalized-merchandise-market
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping) Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping)-Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Esports Market by Revenue Streams (Media Rights (Subscription & Online Advertisement), Tickets and Merchandise, Sponsorship & Direct Advertisement, and Publisher Fees), and Geography (North America, Europe, APAC, and RoW) - Global Forecast to 2035
The market is mainly driven by the increasing popularity of video games and growing awareness about esports. The esports ecosystem comprises companies such as Modern Times Group (Sweden), Activision Blizzard (US), FACEIT (UK), Total Entertainment Network (US), Gfinity (UK), Turner Broadcasting System (US), CJ Corporation (South Korea), Valve Corporation (US), Tencent (China), and Electronic Arts (EA) (US). This report also covers the following prominent players: Hi-Rez Studios (US), KaBuM (Canada), Wargaming Public (Cyprus), Rovio Entertainment (Finland), GungHo Online Entertainment (Japan), and Alisports (China). Online streaming companies such as YouTube(US), Twitch (US), Facebook (US), and Beyond the Summit (BTS) (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Electronic Article Surveillance Market by Component (Tags, Antennas & Detachers), Technology, End User (Apparel & Fashion Accessories Stores, Supermarket & Mass Merchandise Stores, Drug & Health Product Stores), and Geography - Global Forecast to 2036
The global electronic article surveillance market was valued at USD 1.18 billion in 2024 and is estimated to reach USD 1.99 billion by 2036, at a CAGR of 4.6% between 2025 and 2036. Modernizing retail sector and protection against inventory losses, shoplifting, and theft are the major driving factors for the market’s growth during the forecast period. Key players in the market include Checkpoint Systems (Canada), Johnson Controls (Ireland), Agon Systems (UK), ALL-TAG Corporation (US), Amersec (Czech Republic), TAG Company (UK), Ketec (US), WG Security Products (US), Softdel (US), Shenzhen Emeno Technology (China), Cross Point (The Netherland), Takachiho Koheki (Japan), Stanley Security (US), Shopguard Systems (Hungary), Dexilon Automation (Spain), Feltron Security Systems (UAE), and Sentry Custom Security (Canada).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Prescriptive Analytics Market by Component, Application (Customer Retention and Engagement and Personalized Recommendation), Deployment Mode, Organization Size, Vertical, Capability, and Region (2022 - 2026)
The prescriptive analytics market size is projected to reach USD 14.3 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. The major vendors in the global prescriptive analytics market include IBM (US), Microsoft (US), Salesforce (US), SAP (Germany), SAS Institute (US), Talend (US), FICO (US), Ayata (US), Altair (US), Alteryx (US), TIBCO (US), Sisense(US) Happiest Minds (India), Zebra (England), Infor (US), RapidMiner (US), Logi Analytics (US), Qlik (US), River Logic (US), Frontline Systems (US), Netformx (US), Mitek Analytics (France), and Panorat.IO (US).
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
Personalized Nutrition Market by Product (Products, Services, Digital Tools), Application (General Lifestyle, Beauty, Skin & Longevity, Weight Management & Metabolic Health), End-use, Personalization Basis, Type, & Region - Global Forecast to 2030
The personalized nutrition market is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% from 2025 to 2030. The report profiles key players such as Abbott (US), Nestlé Health Science (Switzerland), Medtronic (Ireland), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (USA), Nutrigenomix (Canada), Rootine (US), Sun Genomics (US), etc.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
